Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages.
Tumor necrosis factor alpha (TNF-alpha) plays an important role in the host immune response to infection with the intracellular pathogen Mycobacterium tuberculosis. It is essential for the formation of protective tuberculous granulomas and regulates the expression of other cytokines which contribute to a protective immune response. Interleukin-12 (IL-12) is known to promote a Th1 response, which is essential for antimycobacterial resistance. Recombinant guinea pig TNF-alpha (rgpTNF-alpha) protein (17 kDa) was purified, and its bioactivity was confirmed by its cytotoxicity for L929 fibroblasts. High titers of polyclonal anti-gpTNF-alpha antibody were obtained by immunization of rabbits. Resident alveolar and peritoneal macrophages were isolated from guinea pigs and infected with either the H37Ra or H37Rv strain of M. tuberculosis. The mRNA levels for TNF-alpha and IL-12 p40 were measured using real-time PCR. IL-12 p40 mRNA was up-regulated in a dose-dependent manner by rgpTNF-alpha alone. In infected macrophages, a lower dose of rgpTNF-alpha intensified the mRNA levels of TNF-alpha and IL-12 p40. However, higher doses of rgpTNF-alpha suppressed TNF-alpha and IL-12 p40 mRNA. The antimycobacterial activity of macrophages was assessed by metabolic labeling of M. tuberculosis with [3H]uracil. Resident alveolar and peritoneal macrophages treated with anti-gpTNF-alpha antibody to block endogenous TNF-alpha exhibited increased intracellular mycobacterial growth. These data suggest that the dose of TNF-alpha is crucial to the stimulation of optimal expression of protective cytokines and that TNF-alpha contributes to the control of mycobacterial replication to promote host resistance against M. tuberculosis.
Cho
Hyosun
H
Department of Medical Microbiology and Immunology, The Texas A&M University System Health Science Center, 407 Reynolds Medical Building, College Station, TX 77843-1114, USA. HScho@medicine.tamu.edu
Lasco
Todd M
TM
Allen
Shannon Sedberry
SS
Yoshimura
Teizo
T
McMurray
David N
DN
D000818:Animals; D006168:Guinea Pigs; D018664:Interleukin-12 / Q000378:metabolism*; D053762:Interleukin-12 Subunit p40; D008262:Macrophage Activation; D016676:Macrophages, Alveolar / Q000276:immunology / Q000382:microbiology*; D017737:Macrophages, Peritoneal / Q000276:immunology / Q000382:microbiology*; D009169:Mycobacterium tuberculosis / Q000254:growth & development* / Q000472:pathogenicity; D021122:Protein Subunits / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D011817:Rabbits; D011994:Recombinant Proteins / Q000276:immunology*; D014376:Tuberculosis / Q000276:immunology / Q000382:microbiology; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology* / Q000378:metabolism; D015854:Up-Regulation
D053762:Interleukin-12 Subunit p40; D021122:Protein Subunits; D012333:RNA, Messenger; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D018664:Interleukin-12
Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8093-8
9223320
J Exp Med. 1997 Jul 7;186(1):39-45
9206995
Am J Physiol. 1997 Sep;273(3 Pt 1):L524-30
9316485
Infect Immun. 1997 Dec;65(12):5149-56
9393809
Infect Immun. 1998 Mar;66(3):927-31
9488377
Infect Immun. 1998 Mar;66(3):1190-9
9488413
Pathobiology. 1998;66(1):24-32
9577963
Infect Immun. 1998 Jun;66(6):2951-9
9596772
J Immunol. 1998 Aug 1;161(3):1447-53
9686610
J Infect Dis. 1998 Aug;178(2):580-4
9697749
Rheum Dis Clin North Am. 1998 Aug;24(3):593-614
9710889
Tuber Lung Dis. 1997;78(3-4):145-58
9713647
Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13806-11
9811882
J Immunol. 1999 Feb 15;162(4):2321-5
9973510
Infect Immun. 1999 Sep;67(9):4531-8
10456896
J Immunol. 1999 Oct 1;163(7):3653-61
10490959
Infect Immun. 1999 Oct;67(10):5473-6
10496932
J Immunol. 2000 Feb 15;164(4):1722-9
10657616
J Leukoc Biol. 2000 Apr;67(4):545-52
10770288
J Immunol. 2000 Jun 1;164(11):5564-74
10820230
Eur J Immunol. 2000 Jun;30(6):1562-7
10898491
Infect Immun. 2000 Dec;68(12):6954-61
11083819
Exp Lung Res. 2001 Jan - Feb;27(1):65-76
11202064
Cell. 2001 Feb 23;104(4):477-85
11239406
Trends Mol Med. 2001 Mar;7(3):135-7
11286786
Eur Respir J. 2001 May;17(5):1049-51
11488308
J Immunol. 2002 Feb 1;168(3):1328-37
11801673
Nat Rev Immunol. 2001 Oct;1(1):20-30
11905811
Infect Immun. 2002 Oct;70(10):5471-8
12228272
Infect Immun. 2003 Jan;71(1):354-64
12496185
Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):193-209
12787559
J Immunol. 2003 Sep 15;171(6):3110-8
12960337
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12420-5
14557547
Infect Immun. 2003 Dec;71(12):7035-42
14638793
Infect Immun. 2004 May;72(5):2976-88
15102810
J Bacteriol. 1967 Oct;94(4):832-5
4964472
Cell. 1989 Mar 10;56(5):731-40
2647299
Infect Immun. 1990 Aug;58(8):2675-7
2115027
J Immunol. 1990 Aug 1;145(3):940-4
2115549
Immunology. 1991 Sep;74(1):60-7
1937574
J Leukoc Biol. 1991 Nov;50(5):495-501
1748843
J Immunol Methods. 1993 Jan 4;157(1-2):91-9
8423377
J Immunol. 1993 Jul 1;151(1):518-25
8100846
J Exp Med. 1993 Dec 1;178(6):2249-54
7504064
Blood. 1994 Apr 1;83(7):1847-55
7908232
J Exp Med. 1995 May 1;181(5):1615-21
7722441
Immunity. 1995 Jun;2(6):561-72
7540941
Cell Immunol. 1995 Jul;163(2):260-7
7606797
J Clin Immunol. 1996 May;16(3):144-50
8734357
Annu Rev Immunol. 1997;15:749-95
9143706
Bone Marrow Transplant. 1997 Sep;20(6):511-5
9313887